Evidence map›Paper›PMID 39350605›Full record

ArticleBritish journal of haematology2024

Prognostic impact of nodal involvement in Waldenström macroglobulinaemia.

Simon Østergaard, Lars Munksgaard, Troels Hammer, Mette Ø Pedersen, Torsten H Nielsen, Lise Mette R Gjerdrum

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Simon ØstergaardDepartment of Pathology, Copenhagen University Hospital - Zealand University Hospital Roskilde, Roskilde, Denmark.ORCID https://orcid.org/0009-0003-3845-1878
Lars MunksgaardDepartment of Hematology, Zealand University Hospital Roskilde, Roskilde, Denmark.
Troels HammerDepartment of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Mette Ø PedersenDepartment of Pathology, Copenhagen University Hospital - Zealand University Hospital Roskilde, Roskilde, Denmark.
Torsten H NielsenDepartment of Hematology, Zealand University Hospital Roskilde, Roskilde, Denmark.
Lise Mette R GjerdrumDepartment of Pathology, Copenhagen University Hospital - Zealand University Hospital Roskilde, Roskilde, Denmark.

Funding

Region Sjælland R32-A1056
6 · The paper itself

Abstract

The clinical and prognostic implications of nodal involvement (NI) in Waldenström macroglobulinaemia (WM) are largely unknown. In this study, we explored the impact of NI on clinical presentation and outcome in a population-based cohort of 469 patients with WM, consecutively diagnosed between 2000 and 2022. NI was detected in 34% of patients and was associated with symptomatic disease, adverse prognostic factors, an increased risk of transformation, and lymphoma-related death. Our findings indicate that NI is of prognostic significance in WM, suggesting a need for enhanced surveillance in these patients.

Indexed as

Waldenstrom MacroglobulinemiaAdultAgedAged, 80 and overFemaleHumansLymph NodesMaleMiddle AgedPrognosisextra‐medullary diseasehistological transformationnon‐Hodgkin's lymphomaprognosisWaldenström's macroglobulinaemia

Identifiers

PMID39350605
PMCPMC11637723

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.